Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin

BACKGROUND: Antimuscarinic agents used in the treatment of overactive bladder (OAB) differ in their potential to impair cognitive function. It is hypothesised that low brain concentrations and relatively low selectivity for the M(1) muscarinic receptor may reduce the potential for adverse central ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Kay, G G, Ebinger, U
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734922/
https://www.ncbi.nlm.nih.gov/pubmed/18699842
http://dx.doi.org/10.1111/j.1742-1241.2008.01849.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734922/
https://www.ncbi.nlm.nih.gov/pubmed/18699842
http://dx.doi.org/10.1111/j.1742-1241.2008.01849.x

Ejemplares similares